Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody

By                        

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1453-1460

Spandidos Publications

Access to resources Recommend Favorite

Growth Inhibition of Insulin-Like Growth Factor I Receptor Monoclonal Antibody to Human Colorectal Cancer Cells

By Zhang Youcheng   Zhang Yawu  

Cancer Investigation, Vol. 26, Iss. 3, 2008-01 ,pp. : 230-236

Informa Healthcare

Access to resources Recommend Favorite

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

By Wu Kai-Da   Zhou Li   Burtrum Douglas   Ludwig Dale   Moore Malcolm  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 343-357

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

By Macaulay V. M.   Middleton M. R.   Protheroe A. S.   Tolcher A.   Dieras V.   Sessa C.   Bahleda R.   Blay J.-Y.   LoRusso P.   Mery-Mignard D.   Soria J.-C.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 784-791

Oxford University Press

Access to resources Recommend Favorite

Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells

By Dong Zhizhen   Yao Min   Wang Li   Yan Xiaodi   Gu Xing   Shi Yun   Yao Ninghua   Qiu Liwei   Wu Wei   Yao Dengfu  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3397-3405

Springer Publishing Company

Access to resources Recommend Favorite